Term
|
Definition
|
|
Term
AA Fibrinogen receptor antagonists mimic |
|
Definition
|
|
Term
|
Definition
Natural thrombin inhibitors |
|
|
Term
|
Definition
- Catalizes plasminogen -> Plasmin
- Hypersensitivity
- short t1/2
- strep AB effective against strepokinase
|
|
|
Term
|
Definition
- t-PA
- Activate plasminogen
- High affinity for plasminogen---fibrin
|
|
|
Term
|
Definition
- Serine protease inhibitor (block plasmin)
|
|
|
Term
|
Definition
- NO receptor
- activate guanylate cyclase: ↑ cGMP
|
|
|
Term
|
Definition
- Made by heart
- Bind guanylate cyclase
- ↑ cGMP
|
|
|
Term
|
Definition
- Activate K channel
- K goes out, prevents Ca channel from opening
- ↓ Ca -> ↓ smooth muscle contraction
↑ NO (↑ CO & ↑ Stroke volume)
|
|
|
Term
|
Definition
- Na channel
- Intermediate
- ↓ phase 0 depolarization
|
|
|
Term
|
Definition
- Na channel
- Fast, low potency
- ↓ phase 3 repolarization
|
|
|
Term
|
Definition
- Na channel
- slow potent
- ↓ phase 0 depolarization
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- K channel
- block K eflux, ↑ repolarization
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Agonist: Vasoconstriction |
|
|
Term
When are CCB proven to be efective? |
|
Definition
patient responds well to an acute vasodilator test |
|
|
Term
|
Definition
prevent cell growth and proliferation |
|
|